Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  fludeoxyglucose F 18
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 162 for your search:
Start Over
Study the Role of Positron Emission Mammography in Pre-surgical Planning for Breast Cancer
Phase: Phase IV
Type: Diagnostic
Status: Closed
Age: 25 and over
Sponsor: Other
Protocol IDs: PEM-06-01, NIH Grant: 5 R44 CA103102-05, NCT00484614
Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer
Phase: Phase III, Phase II
Type: Diagnostic
Status: Completed
Age: 15 and over
Sponsor: Other
Protocol IDs: SP-11-0035/DX-FDG-001/21221, NCT00123760
Digital Mammography, Ultrasound, MRI, and PET Scans in Women With Newly Diagnosed Breast Cancer
Phase: Phase III, Phase II
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000515329, UPCC-12199, UPCC-414500, NCT00194337
Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Lymphoma
Phase: Phase III
Type: Diagnostic, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CALGB-50303, CDR0000433265, NCI-2009-00480, U10CA031946, U10CA180821, ECOG-50303, NCI-05-C-0252, NCT00118209
Utility of FDG-PET Scan on the Selection of Patients for Resection of Hepatic Colorectal Metastases
Phase: Phase III
Type: Diagnostic, Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: POLEM (ZonMW DO 945-11017), (ZonMW DO 945-11017), NCT00119899
Usefulness of FDG-PET for Advanced Cervical Cancer
Phase: Phase III
Type: Diagnostic
Status: Closed
Age: no age specified
Sponsor: Other
Protocol IDs: CTRP024, NSC 92-2314-B-182A-084, NCT00146458
Positronic Emission Tomography (PET) Imaging in Post Radiation Evaluation of Head and Neck Tumours (PET PREVENT Trial)
Phase: Phase III
Type: Diagnostic
Status: Completed
Age: 18 to 80
Sponsor: Other
Protocol IDs: CTA-Control-088421, NCT00147472
PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial)
Phase: Phase III
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CTA-Control-092493, NCT00201942
PET and MRI in the Follow-up of Neoadjuvant Chemotherapy of Breast Cancer
Phase: Phase III
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: P020907, NCT00236275
Early On-therapy PET at First-line Treatment in Diffuse Large B-cell Lymphoma Stage IIB-IV
Phase: Phase III
Type: Diagnostic, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: NLG PET Study, NCT00286832
Fludeoxyglucose F 18 PET Scan-Guided Therapy or Standard Therapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 15 to 70
Sponsor: Other
Protocol IDs: EORTC-20051, GELA-H10, IIL-EORTC-20051, EUDRACT-2005-002765-37, EU-20657, NCT00433433
PET Scan in Planning Treatment in Patients Undergoing Combination Chemotherapy For Stage IA or Stage IIA Hodgkin Lymphoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 to 75
Sponsor: Other
Protocol IDs: 03_DOG05_07, CHNT-RAPID, ISRCTN99811594, EU-20931, RAPID, NCT00943423
Fludeoxyglucose F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer
Phase: Phase II, Phase I
Type: Diagnostic
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00600, CDR0000521453, ACRIN 6671, GOG-0233/ACRIN 6671, GOG-0233, U10CA180868, U10CA027469, NCT00416455
A Study of Changes in FDG- and FLT-PET Imaging in Patients With Non-Small Cell Lung Cancer Following Treatment With Erlotinib
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: OSI3926g, ML20773, NCT00453362
Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Over 18
Sponsor: Other
Protocol IDs: EORTC-24051, 2006-002667-33, GSK-EORTC-24051, EUDRACT-2006-002667-33, NCT00498953
Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000573917, NCCTG-N057K, N057K, NCT00553150
Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00267, MGH-07-344, R01CA129371, CDR0000593717, PHS 398/2590, 8030, P30CA006516, 07-344, NCT00662506
Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas
Phase: Phase II
Type: Treatment
Status: Closed
Age: 4 to 35
Sponsor: NCI
Protocol IDs: 020259, 02-C-0259, NCI-02-C-0259, NCT00047372, NCT00043979
Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction
Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01438, 03-032, NCI-5917, CDR0000304738, MSKCC-03032, 5917, NCT00062374
Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000362061, ACRIN-6668, RTOG-0235, NCT00083083
FDG-PET to Investigate SGN-15 and Docetaxel in Patients With Advanced Non-Small Cell Lung Carcinoma
Phase: Phase II
Type: Diagnostic, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SG015-0005, NCT00086333
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CDR0000426417, ACOSOG-Z4033, SRC1, NCT00109876
Positron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Phase: Phase II
Type: Diagnostic, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 6228, P30CA015704, UWCC-6228, UWCC-UW-6228, UW-04033, LILY-UW-04033, CDR0000441239, NCT00227539
Start Over